Timing of last COVID-19 vaccine dose and SARS-CoV-2 breakthrough infections in fully (boosted) vaccinated healthcare personnelArticle Published on 2023-02-012023-07-11 Journal: The Journal of hospital infection [Category] [DOI] 10.1016/j.jhin.2022.11.016 PMC 바로가기
Strategies to tackle SARS-CoV-2 Mu, a newly classified variant of interest likely to resist currently available COVID-19 vaccines현재 사용 가능한 COVID-19 백신에 저항할 가능성이 있는 새로 분류된 관심 변종인 SARS-CoV-2 Mu에 대처하기 위한 전략Article Published on 2022-12-312022-09-11 Journal: Human vaccines & immunotherapeutics [Category] [DOI] 10.1080/21645515.2022.2027197 PMC 바로가기 [Article Type] Article
Acceptance of the COVID-19 vaccine booster dose and associated factors among the elderly in China based on the health belief model (HBM): A national cross-sectional studyArticle Published on 2022-12-152023-07-11 Journal: Frontiers in Public Health [Category] [DOI] 10.3389/fpubh.2022.986916 PMC 바로가기
Safety and immunogenicity of inactivated SARS-CoV-2 vaccines in people living with HIVHIV 보균자에서 비활성화된 SARS-CoV-2 백신의 안전성 및 면역원성Observational Study Published on 2022-12-012022-09-12 Journal: Emerging Microbes & Infections [Category] [DOI] 10.1080/22221751.2022.2059401 PMC 바로가기 [Article Type] Observational Study
A case-case study on the effect of primary and booster immunization with China-produced COVID-19 vaccines on prevention of pneumonia and viral load among vaccinated persons infected by Delta and Omicron variantsDelta 및 Omicron 변종에 감염된 백신 접종자의 폐렴 및 바이러스 부하 예방에 대한 중국산 COVID-19 백신의 1차 및 추가 접종 효과에 대한 사례 연구Article Published on 2022-12-012022-09-11 Journal: Emerging Microbes & Infections [Category] [DOI] 10.1080/22221751.2022.2103455 PMC 바로가기 [Article Type] Article
Humoral responses after inactivated COVID-19 vaccination in individuals with and without prior SARS-CoV-2 infection: A prospective cohort studyArticle Published on 2022-12-012022-11-15 Journal: Journal of medical virology [Category] [DOI] 10.1002/jmv.28055 PMC 바로가기
Humoral response and safety of the third booster dose of BNT162b2 mRNA COVID-19 vaccine in patients with multiple sclerosis treated with ocrelizumab or fingolimodArticle Published on 2022-12-012022-11-15 Journal: Journal of Neurology [Category] [DOI] 10.1007/s00415-022-11296-4 PMC 바로가기
Effectiveness of vaccination against SARS-CoV-2 Omicron variant infection, symptomatic disease, and hospitalization: a systematic review and meta-analysisMeta-Analysis Published on 2022-12-012023-07-10 Journal: Expert review of vaccines [Category] [DOI] 10.1080/14760584.2022.2130773 PMC 바로가기 [Article Type] Meta-Analysis
Immunogenicity and Safety of SpikoGen, an Adjuvanted Recombinant SARS-CoV-2 Spike Protein, as a Heterologous Third Booster Dose in Kidney Transplant Patients: A Single-arm Clinical TrialClinical Trial Published on 2022-12-012023-07-10 Journal: Clinical therapeutics [Category] [DOI] 10.1016/j.clinthera.2022.10.002 PMC 바로가기 [Article Type] Clinical Trial
Vaccine effectiveness and duration of protection against symptomatic infections and severe Covid-19 outcomes in adults aged 50 years and over, France, January to mid-December 2021Research article Published on 2022-12-012022-10-05 Journal: Global Epidemiology [Category] [DOI] 10.1016/j.gloepi.2022.100076 [Article Type] Research article